Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Johnson and Johnson
Baxter
McKinsey

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Hydroxyethyl cellulose

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Hydroxyethyl cellulose?

Hydroxyethyl cellulose is an investigational drug.

There have been 4 clinical trials for Hydroxyethyl cellulose. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2012.

The most common disease conditions in clinical trials are Vaginosis, Bacterial, Vaginal Diseases, and Vaginitis. The leading clinical trial sponsors are CONRAD, Starpharma Pty Ltd, and National Institutes of Health (NIH).

There are two US patents protecting this investigational drug and twenty international patents.

Recent Clinical Trials for Hydroxyethyl cellulose
TitleSponsorPhase
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04National Institutes of Health (NIH)Phase 1
A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04CONRADPhase 1

See all Hydroxyethyl cellulose clinical trials

Clinical Trial Summary for Hydroxyethyl cellulose

Top disease conditions for Hydroxyethyl cellulose
Top clinical trial sponsors for Hydroxyethyl cellulose

See all Hydroxyethyl cellulose clinical trials

US Patents for Hydroxyethyl cellulose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Hydroxyethyl cellulose   Start Trial Rubbers with tunable levels of metal containing anti-agglomerants ARLANXEO Singapore Pte. Ltd. (Singapore, SG)   Start Trial
Hydroxyethyl cellulose   Start Trial Printing ink dispersions comprising discrete carbon nanotubes Molecular rebar Design, LLC (Austin, TX)   Start Trial
Hydroxyethyl cellulose   Start Trial Protective flowable or spreadable composition, articles of manufacture, an apparatus for manufacture and a process for manufacture thereof   Start Trial
Hydroxyethyl cellulose   Start Trial Fracturing or gravel-packing fluid with CMHEC in brine Halliburton Energy Services, Inc. (Houston, TX)   Start Trial
Hydroxyethyl cellulose   Start Trial Composition of redox-reagents for electrochemical biosensor and biosensor comprising the same I-SENS, INC. (Seoul, KR)   Start Trial
Hydroxyethyl cellulose   Start Trial Compositions and methods for the treatment of intraocular neovascularization and/or leakage Retinal Therapies, LLC (Coronado, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Hydroxyethyl cellulose

Drugname Country Document Number Estimated Expiration Related US Patent
Hydroxyethyl cellulose Canada 2934807 2033-12-23   Start Trial
Hydroxyethyl cellulose China 106232709 2033-12-23   Start Trial
Hydroxyethyl cellulose European Patent Office 3087138 2033-12-23   Start Trial
Hydroxyethyl cellulose Japan 2017502152 2033-12-23   Start Trial
Hydroxyethyl cellulose Japan 6523297 2033-12-23   Start Trial
Hydroxyethyl cellulose South Korea 20160115921 2033-12-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Moodys
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.